Anhui Provincial Hospital

This study is testing whether a specific injection can help protect the liver from damage during and after surgery to remove part of the liver for cancer. Researchers will compare two groups: one receives the liver-protecting injection before surgery and a combination of injectio…

This early-stage study is testing a new treatment for a severe complication called graft-versus-host disease (GVHD) that can happen after a bone marrow or stem cell transplant. The treatment uses special cells (iMSCs) grown in a lab from stem cells. Researchers want to see if the…

This early study is testing a new treatment called LCAR02, a gene injection designed to target CD19 on cancer cells, in up to 18 adults with B-cell lymphoma that has come back or not responded to standard treatments. The main goals are to check the safety of the treatment and see…

This study is testing a new combination treatment for people with advanced esophageal cancer that has worsened after their first treatment. It combines an immunotherapy drug called Ivonescimab with a short, intense course of radiation. The main goals are to see if this approach c…

This study is testing if the time of day a patient receives a cord blood stem cell transplant affects their risk of developing a serious complication called acute graft-versus-host disease (GVHD). It will enroll 134 patients with blood cancers who are in remission and scheduled f…

This early-stage study is testing whether infusions of cells from donated umbilical cord blood can help improve or stabilize thinking skills and daily function in people with Alzheimer's disease. Thirty participants with mild to moderate Alzheimer's will receive either a low dose…

This early-phase study is testing the safety and initial effectiveness of a new type of cell therapy called Meta10-TIL for people with advanced solid tumors that have stopped responding to standard treatments. Doctors take a patient's own immune cells from their tumor, modify the…

This study aims to find the best length of time for kidney transplant patients to take a preventive antibiotic to stop a serious lung infection called PJP. Researchers will enroll 450 patients to compare different treatment durations and measure drug levels in the blood. The goal…